Description

G-protein coupled receptor signaling bias induced by different phytocannabinoids is depicted. Biased agonism at CB1 receptors may explain differential therapeutic profiles.

Figure 429

Diagram

Source Paper

Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy.

Pharmaceuticals (Basel, Switzerland) (2020)

PMID: 32751761

DOI: 10.3390/ph13080174

Cite This Figure

![Figure 429: G-protein coupled receptor signaling bias induced by different phytocannabinoids is depicted. Biased agonism at CB1 receptors may explain differential therapeutic profiles.]()

> Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." *Pharmaceuticals (Basel, Switzerland)*, 2020. PMID: [32751761](https://pubmed.ncbi.nlm.nih.gov/32751761/)

<figure>
  <img src="" alt="G-protein coupled receptor signaling bias induced by different phytocannabinoids is depicted. Biased agonism at CB1 receptors may explain differential therapeutic profiles." />
  <figcaption>Figure 429. G-protein coupled receptor signaling bias induced by different phytocannabinoids is depicted. Biased agonism at CB1 receptors may explain differential therapeutic profiles.<br>  Source: Lara Senn et al. "Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Se." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751761/">32751761</a></figcaption>
</figure>

Related Evidence

CBD for Insomnia

Grade A · 103 studies